Investment Rating - The industry investment rating is "Outperform the Market - A" [4] Core Viewpoints - The PVC market has shown signs of recovery, with prices increasing to 4547 RMB/ton as of February 25, 2026, representing a 6.8% rise since the beginning of the year [2][8] - The recovery in PVC prices is expected to boost demand for additives, as the overall sentiment in the supply chain becomes more positive, leading to increased procurement of high-performance additives [2][9] - The industry is experiencing a structural improvement in supply and demand dynamics, driven by a combination of supply-side reductions and steady demand growth [8][9] Summary by Relevant Sections PVC Market Recovery - The PVC market is recovering due to various factors, including the deepening of "anti-involution" policies and the gradual implementation of differentiated electricity pricing [2] - The price of PVC has shown a steady upward trend, indicating a positive market sentiment [2] Additives Industry Outlook - Additives play a crucial role in enhancing the performance of PVC products and optimizing processing techniques [2] - The demand for high-performance additives is expected to increase as downstream manufacturers show a greater willingness to operate [2][9] Additive Types and Market Dynamics - The PVC additives market includes various key products such as acetylacetone salts, Saik, DBM/SBM, ACR, MBS, and MC [2][9] - The acetylacetone market is experiencing a dual drive of supply disruptions and steady demand growth, leading to price increases [8] - The industry is undergoing a phase of capacity clearance, which is expected to improve the supply-demand structure and lead to price recovery for other additive types [9] Key Companies in the Industry - Key companies in the PVC additives sector include: - Jianbang Co., Ltd. with capacities for acetylacetone salts and Saik [11] - Ruifeng High Materials, a leading enterprise with significant production capacity for ACR and MBS [11] - Rike Chemical with substantial production capacity for ACR and ACM series products [11] - Xinhua Pharmaceutical with acetylacetone salt production capacity [11] - Jiaxian Co., Ltd. with DBM/SBM production capacity [11]